Volume 17, Issue 3 (11-2003)                   Med J Islam Repub Iran 2003 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
ALBORZI S, ROBATI M, PARSANEJAD M E. THE EFFICACY OF HYSTEROSCOPIC ADHESIOLYSIS IN ASHERMAN'S SYNDROME . Med J Islam Repub Iran 2003; 17 (3) :185-187
URL: http://mjiri.iums.ac.ir/article-1-678-en.html
THE EFFICACY OF HYSTEROSCOPIC ADHESIOLYSIS IN ASHERMAN'S SYNDROME
SAEED ALBORZI , MINOO ROBATI , MOHAMMAD E. PARSANEJAD
From the Department of Obstetrics and Gynecology. Shiraz University of Medical Sciences. Shiraz. I.R. Iran
Abstract:   (4912 Views)
To determine the prevalence of Asherman's syndrome in the south of Iran and assess the safety and efficacy of hysteroscopic adhesiolysis in restoration of menstrual function and fertility, a prospective study was done from 1997 to 1999. Among 2300 couples with infertility referring to the infertility clinic of a Shiraz University hospital, 30 patients were proven to have Asherman's syndrome by diagnostic hysterosalpingography (HSG) and then hysteroscopy. T he prevalence of this syndrome was 1.3%. Hysteroscopic adhesiolysis was performed in all 30 patients. Adhesion reformation postoperatively was absent in stage 1 patients, 15% in stage II and 66% in stage III. Normal menstrual flow was restored in all patients (100%), and 19 patients (63.3%) conceived after surgery that resulted in term infants in 15 patients (50%). Hysteroscopic adhesiolysis is. a safe and effective operation for restoring the normal menstrual pattern and fertility, and the severity of the adhesions appear to correlate best with the reproductive outcome.
Keywords: Intrauterine adhesions, Hysteroscopic adhesiolysis, Infertility.
Full-Text [PDF 219 kb]   (2249 Downloads)    
Type of Study: Original Research | Subject: Gynecology & Obstetrics
Add your comments about this article : Your username or Email:
CAPTCHA
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.